E-LIB Suche - Ergebnisse für: Bellezza, Guido

1

Correction: Repotrectinib's Clinical Benefit and Its Brain ..:

Metro, Giulio ; Gariazzo, Eleonora ; Costabile, Silvia...
Oncology and Therapy. 12 (2024) 1 - p. 173-174 , 2024

2

Subcellular distribution and Nrf2/Keap1-interacting propert..:

Bartolini, Desirée ; Stabile, Anna Maria ; Migni, Anna...
Archives of Biochemistry and Biophysics. 757 (2024) - p. 110043 , 2024

Link: https://doi.org/10.1016/..

3

Urinary diagnostic cytology beyond the research of neoplast..:

Del Sordo, Rachele ; Covarelli, Carla ; Annese, LuciaC...
Journal of Cytology. 40 (2023) 4 - p. 200 , 2023

Link: https://doi.org/10.4103/..

4

Repotrectinib's Clinical Benefit and Its Brain Penetration ..:

Metro, Giulio ; Gariazzo, Eleonora ; Costabile, Silvia...
Oncology and Therapy. 12 (2023) 1 - p. 163-171 , 2023

Link: https://doi.org/10.1007/..

5

Polyangiitis overlap syndrome: a rare clinical entity:

Bruno, Lorenza ; Mandarano, Martina ; Bellezza, Guido...
Rheumatology International. 43 (2023) 3 - p. 537-543 , 2023

Link: https://doi.org/10.1007/..

6

Analysis of neuroendocrine clones in NSCLCs using an immuno..:

Baldelli, Elisa ; Mandarano, Martina ; Bellezza, Guido..
Cell Reports Methods. 2 (2022) 8 - p. 100271 , 2022

Link: https://doi.org/10.1016/..

7

Inflamed Tumor Phenotype as Predictor of Long-Term Response..:

Baglivo, Sara ; Mandarano, Martina ; Bellezza, Guido...
Oncology and Therapy. 10 (2022) 1 - p. 291-300 , 2022

Link: https://doi.org/10.1007/..

8

Looking for more reliable biomarkers in breast cancer: Comp..:

Caselli, Emanuele ; Pelliccia, Cristina ; Teti, Valeria...
PLOS ONE. 16 (2021) 9 - p. e0255580 , 2021

Link: https://doi.org/10.1371/..

9

Higher TLR7 Gene Expression Predicts Poor Clinical Outcome ..:

Baglivo, Sara ; Bianconi, Fortunato ; Metro, Giulio...
Genes. 12 (2021) 7 - p. 992 , 2021

Link: https://doi.org/10.3390/..

10

PD-L1 quantification across tumor types using the reverse p..:

Baldelli, Elisa ; Hodge, K Alex ; Bellezza, Guido...
Journal for ImmunoTherapy of Cancer. 9 (2021) 10 - p. e002179 , 2021

Link: https://doi.org/10.1136/..

11

Sensitivity to Immune Checkpoint Blockade in Advanced Non-S..:

Metro, Giulio ; Baglivo, Sara ; Bellezza, Guido...
Genes. 12 (2021) 5 - p. 679 , 2021

Link: https://doi.org/10.3390/..

12

High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are A..:

Ludovini, Vienna ; Bianconi, Fortunato ; Siggillino, Annamaria...
Genes. 12 (2021) 2 - p. 273 , 2021

Link: https://doi.org/10.3390/..

13

Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biom..:

Mandarano, Martina ; Orecchini, Elena ; Bellezza, Guido...
International Journal of Molecular Sciences. 22 (2021) 9 - p. 4403 , 2021

Link: https://doi.org/10.3390/..

14

Impact of Epithelial–Mesenchymal Immunophenotype on Local A..:

Mandarano, Martina ; Andolfi, Marco ; Colella, Renato...
Journal of Clinical Medicine. 10 (2021) 19 - p. 4351 , 2021

Link: https://doi.org/10.3390/..

15

Current Challenges for IDO2 as Target in Cancer Immunothera..:

Mondanelli, Giada ; Mandarano, Martina ; Belladonna, Maria Laura...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..